These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15347805)

  • 1. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
    Lee Y; Naseem RH; Duplomb L; Park BH; Garry DJ; Richardson JA; Schaffer JE; Unger RH
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13624-9. PubMed ID: 15347805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice.
    Lee Y; Naseem RH; Park BH; Garry DJ; Richardson JA; Schaffer JE; Unger RH
    Biochem Biophys Res Commun; 2006 May; 344(1):446-52. PubMed ID: 16603124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
    Jeong MH; Tran NK; Kwak TH; Park BK; Lee CS; Park TS; Lee YH; Park WJ; Yang DK
    PLoS One; 2014; 9(3):e91039. PubMed ID: 24614171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.
    Liu L; Shi X; Bharadwaj KG; Ikeda S; Yamashita H; Yagyu H; Schaffer JE; Yu YH; Goldberg IJ
    J Biol Chem; 2009 Dec; 284(52):36312-36323. PubMed ID: 19778901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice.
    Ueno M; Suzuki J; Zenimaru Y; Takahashi S; Koizumi T; Noriki S; Yamaguchi O; Otsu K; Shen WJ; Kraemer FB; Miyamori I
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1109-18. PubMed ID: 18413675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of cardiac carnitine palmitoyltransferase to malonyl-CoA is regulated by leptin: similarities with a model of endogenous hyperleptinemia.
    Guzmán-Ruiz R; Somoza B; Gil-Ortega M; Merino B; Cano V; Attané C; Castan-Laurell I; Valet P; Fernández-Alfonso MS; Ruiz-Gayo M
    Endocrinology; 2010 Mar; 151(3):1010-8. PubMed ID: 20056820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
    Vikramadithyan RK; Hirata K; Yagyu H; Hu Y; Augustus A; Homma S; Goldberg IJ
    J Pharmacol Exp Ther; 2005 May; 313(2):586-93. PubMed ID: 15671204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mouse model of lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Ford DA; Hsu FF; Garcia R; Herrero P; Saffitz JE; Schaffer JE
    J Clin Invest; 2001 Apr; 107(7):813-22. PubMed ID: 11285300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction.
    Park M; Wu D; Park T; Choi CS; Li RK; Cheng KK; Xu A; Sweeney G
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E795-804. PubMed ID: 23921137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipotoxic diseases.
    Unger RH
    Annu Rev Med; 2002; 53():319-36. PubMed ID: 11818477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.
    Moriyama T; Kishimoto K; Nagai K; Urade R; Ogawa T; Utsumi S; Maruyama N; Maebuchi M
    Biosci Biotechnol Biochem; 2004 Feb; 68(2):352-9. PubMed ID: 14981298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
    Pillutla P; Hwang YC; Augustus A; Yokoyama M; Yagyu H; Johnston TP; Kaneko M; Ramasamy R; Goldberg IJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1229-35. PubMed ID: 15701679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages modulate cardiac function in lipotoxic cardiomyopathy.
    Schilling JD; Machkovech HM; Kim AH; Schwendener R; Schaffer JE
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(11):H1366-73. PubMed ID: 23042950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats.
    Furuyashiki T; Ogawa R; Nakayama Y; Honda K; Kamisoyama H; Takata H; Yasuda M; Kuriki T; Ashida H
    Nutr Res; 2013 Sep; 33(9):743-52. PubMed ID: 24034574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
    Hsu SC; Huang CJ
    J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and tissue-specific regulation of acyl-CoA metabolism.
    Ellis JM; Bowman CE; Wolfgang MJ
    PLoS One; 2015; 10(3):e0116587. PubMed ID: 25760036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
    Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.